1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. BLOCKCHAIN IN THE HEALTHCARE MARKET BY APPLICATION
5.1. Introduction
5.2. Clinical Data Exchange and Interoperability
5.3. Claims Adjudication and Billing Management
5.4. Drug Supply Chain Management
5.5. Clinical Trials and Research Studies
5.6. Medical Records Management
5.7. Others
6. BLOCKCHAIN IN THE HEALTHCARE MARKET BY END-USER
6.1. Introduction
6.2. Healthcare Providers
6.3. Pharmaceutical Companies
6.4. Healthcare Payers
6.5. Patients
6.6. Others
7. BLOCKCHAIN IN THE HEALTHCARE MARKET BY TYPE
7.1. Introduction
7.2. Public Blockchain
7.3. Private Blockchain
7.4. Consortium Blockchain
8. BLOCKCHAIN IN THE HEALTHCARE MARKET BY DEPLOYMENT
8.1. Introduction
8.2. On-Premises
8.3. Cloud-Based
9. BLOCKCHAIN IN THE HEALTHCARE MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. Germany
9.4.2. France
9.4.3. United Kingdom
9.4.4. Spain
9.4.5. Others
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. India
9.6.3. Japan
9.6.4. South Korea
9.6.5. Indonesia
9.6.6. Thailand
9.6.7. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. IBM Corporation
11.2. Microsoft Corporation
11.3. Accenture PLC
11.4. Change Healthcare
11.5. Guardtime
11.6. Hashed Health
11.7. Medicalchain
11.8. Factom, Inc.
11.9. Chronicled, Inc.
11.10. Proof.Work
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES